期刊文献+

多囊卵巢综合征妇女内源性胰岛素释放与睾酮反应的相关性研究 被引量:5

Study on correlation between endogenous insulin release and testosterone response in women with PCOS
下载PDF
导出
摘要 本研究以36例PCOS妇女和20例正常月经周期妇女为研究对象。通过测定激素基础水平,观察在糖耐量试验中胰岛素对糖负荷的反应和睾酮的变化以及分析体脂与胰岛素的关系。发现PCOS妇女有较高的空腹血糖水平、空腹血清胰岛素与空腹血清睾酮呈显著正相关(r=0.65,P<0.01)。在糖负荷期PCOS组血清胰岛素释放显著高于对照组(P<0.01),同时,总睾酮与总胰岛素呈正相关(r=0.69,P<0.01)。PCOS肥胖者总胰岛素对糖负荷的反应最大,对照非肥胖者反应最小(F=3.02,P<0.01)。PCOS妇女体脂百分率与空腹血清胰岛素呈正相关(r=0.523,P<0.05)。由此提示(1)PCOS妇女内源性胰岛素释放是PCOS雄激素增高的原因之一;(2)PCOS妇女体脂过多可能在PCOS的高胰岛素血症和胰岛素抵抗中起有部分作用。 36 women with PCOS (polycystic ovary syndrome) and 20 women withregular cycles were investigated in this study, by measurement of basic hormone levels,observation of alteration of testosterone and insulin response to glucose challenge duringglucose tolerance and analysed the percentage of body fat (BFP). Increase of fastingblood glucose levels and a significant positive correlation between fasting serum insulinlevels and fasting serum testosterone levels (r=0.65, P<0.01) were verified in womenwith PCOS. It was found that the maximum level of insulin release in PCOS groupduring glucose challenge were very much higher than that of control group (P<0.01),meanwhile, there was a definite positive correlation between total insulin response and totaltestosterone (r=0.69, P<0.01) in PCOS group. We found an extremely high insulinresponse in obese-PCOS women, but little in nonobese control women (F=3.02, p<0 .01).Also was a positive correlation between BFP and fasting serum insulin levels (r=0.523,P<0.05) in women with PCOS. In summary, these results suggested that (1) Endogenousinsulin release was one of the causes of hyperandrogenism in women with PCOS, and (2)excess body fat might play a role in hyperinsulinemia and insulin resistance of PCOS.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 1993年第1期62-65,共4页 Chinese Journal of Pathophysiology
关键词 睾酮 胰岛素 多囊卵巢 综合征 Testosterone Insulin Polycystic ovary syndrome
  • 相关文献

同被引文献24

  • 1张颖,沃剡.胰岛素抵抗的研究进展[J].中国社区医师(医学专业),2004,6(24):2-3. 被引量:1
  • 2王小萍,胡丽莎.罗格列酮与二甲双胍联用治疗多囊卵巢综合征胰岛素抵抗[J].实用中西医结合临床,2005,5(5):52-53. 被引量:1
  • 3李秀均主编.胰岛素抵抗综合征:第1版[M].北京:人民卫生出版社,2001.58-79.
  • 4[2]Prelevic GM.Insulin resistance in polycystic ovary syndrome.CurrOp in Obstet Gynecol,1997,4:193-201.
  • 5[4]The Rotterdam ESHRE /ASRM Sponsored PCOS Consensus Workshop Group.Rivised 2003 consensus on dignostic criteria and longterm health risked related to polycystic ovary syndrome.Fertility and Sterility,2004,81:19-25.
  • 6[6]Nestler JE.Role of hyperinsulinemia in the pathologenesis of polycystic ovary syndrome,and its clinical imp lication.Semia Rep rod Engdocrinol,1997,15:111-122.
  • 7[7]Vandermolen DT,Ratts VS,Evans WS.Metform in increase the ovulatory rate and p regnancy rate from clomiphene citrate in patientswith polycystic ovary syndrome who are resistant to clomophene cirate alone.Fertil Steril,2001,75:310-315.
  • 8石湘云 姚松朝 杨晔.体液因素与临床疾病[M].北京:北京医科大学中国协和医科大学联合出版社,1997.296.
  • 9Nestler JE. Role of hypefirtsulinemia in the pathologenesis of polycystic ovary syndrome, and its clinical implication [ J]. Semia Reprod Engdocrinol,1997,15 (2) :111-122.
  • 10Vandermolen DT, Ratts VS, Evans WS. Mefform in increase the ovulatory rate and pregnancy rate from elomiphene citrate in patients with polyeystie ovary syndrome who are resistant to clomophene cirate alone[ J]. Fertil Steril,2001,75 (2) :310-315.

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部